Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons

Neurology

Volumn 72, Issue 20, 2009, Pages 1720-1726

  Hoffman, L B ^a,c   Schmeidler, J ^a   Lesser, G T ^a,b   Beeri, M S ^a   Purohit, D P ^a   Grossman, H T ^a,c   Haroutunian, V ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Jewish Home and Hospital   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN REGION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; BLOOD PRESSURE; BRAIN; DEMENTIA; HISTOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; DEMENTIA; FEMALE; HUMANS; HYPERTENSION; NEUROFIBRILLARY TANGLES; RISK FACTORS; SENILE PLAQUES;

EID: 66149096646     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000345881.82856.d5     Document Type: Article

References (40)

1. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-551.
2. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 2008; 138:353-364.
3. Peila R, White LR, Petrovich H, et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia Aging Study. Stroke 2001;32:2882-2887.
4. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000;21:49-55.
5. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann NY Acad Sci 2002;977:29-36.
6. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-1168.
7. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001;58:1640-1646.
8. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 2003;51:410-414.
9. Lindsay J, Laurin D, Verreault R, et al. Risk Factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156:445-453.
10. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347: 1141-1145.
11. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-l451.
12. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31:780-786.
13. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS: Honolulu-Asia Aging Study. Neurobiol Aging 2000;21:57-62.
14. Korf ESC, White LR, Scheltens P, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004;44:29-34.
15. Guo ZC, Fratiglioni L, Zhu L, Fastbom J, Winbald B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relation- ship of antihypertensive medication use. Arch Neurol 1999;56:991-996.
16. Khachaturian AS, Zandi PP, Lyketsos CG, et al. Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol 2006;63:686-692.
17. Hajjar L, Catoe H, Sixta S, et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol Ser A Biol Sci Med Sci 2005;60:67-73.
18. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-2052.
19. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001;12:33-39.
20. Skoog I, Lithell H, Hansson L, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on Cognition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005;18:1052-1059.
21. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994;154:2154-2160.
22. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ 1996;312:801-805.
23. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance: The Framingham Study. Am J Epidemiol 1987;126:1103-1114.
24. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-689.
25. Pathological correlates of late-onset dementia in a multi-centre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-175.
26. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopath-ologic study. Arch Neurol 2005;62:758-765.
27. Hestad K, Kveberg B, Engedal K. Low blood pressure is a better predictor of cognitive deficits than the apolipopro-tein e4 allele in the oldest old. Acta Neurol Scand 2005; 111:323-328.
28. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003;61:1667-1672.
29. Paran E, Anson O, Reuveni H. Blood pressure and cognitive functioning among independent elderly. Am J Hypertens 2003;16:818-826.
30. Mirra SS, Heyman A, McKeel D, et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
31. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
32. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898.
33. Wang J, Ho L, Chen L, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 2007; 117:3393-3402.
34. Morris JC, Ernesto C, Schafer K, et al. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology 1997;48:1508-1510.
35. Haroutunian V, Purohit DP, Perl DP, et al. Neurofibril-lary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 1999;56:713-718.
36. Haroutunian V, Perl DP, Purohit DP, et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 1998;55:1185-1191.
37. Haroutunian V, Schnaider-Beeri M, Schmeidler J, et al. Alzheimer's disease neuropathology is not sufficient to explain dementia in the oldest-old. Arch Neurol 2008;65: 1211-1217.
38. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
39. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
40. Anson O, Paran E. Hypertension and cognitive functioning among the elderly: an overview. Am J Ther 2005;12: 359-365.